Abstract: A process receives, with a processor, video content. Further, the process splices, with the processor, the video content into a plurality of video frames. In addition, the process splices, with the processor, at least one of the plurality of video frames into a plurality of image patches. Moreover, the process performs, with a neural network, an image reconstruction of at least one of the plurality of image patches to generate a reconstructed image patch. The process also compares, with the processor, the reconstructed image patch with the at least one of the plurality of image patches. Finally, the process determines, with the processor, a pixel error within the at least one of the plurality of image patches based on a discrepancy between the reconstructed image patch and the at least one of the plurality of image patches.

Abstract: A process receives, with a processor, video content. Further, the process splices, with the processor, the video content into a plurality of video frames. In addition, the process splices, with the processor, at least one of the plurality of video frames into a plurality of image patches. Moreover, the process performs, with a neural network, an image reconstruction of at least one of the plurality of image patches to generate a reconstructed image patch. The process also compares, with the processor, the reconstructed image patch with the at least one of the plurality of image patches. Finally, the process determines, with the processor, a pixel error within the at least one of the plurality of image patches based on a discrepancy between the reconstructed image patch and the at least one of the plurality of image patches.

Abstract: Sulphonamide derivatives of alicyclic amines of formula (I), wherein A represents naphthyl or 9- or 10-membered bicyclic group, consisting of benzene ring fused with 5- or 6-membered heterocyclic ring; D represents phenyl, naphthyl, 5-membered aromatic heterocyclic group, bicyclic group consisting of a ring selected from benzene and pyridine, fused with aromatic or non-aromatic 5-membered heterocyclic ring; p, r independently represent 0 or 1; x, z independently represent 1 or 2; n is 2 or 3; and enancjomers, pharmaceutically acceptable salts and solvates thereof. The compounds may be useful for the treatment and/or prevention of the central nervous system disorders.